Yale School of Medicine


 

ACC 21 Highlights: Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction. Results of the LIFE Trial

235 views
June 14, 2021
0 Comments
Login to view comments. Click here to Login
Yale Cardiovascular Medicine Grand Rounds